Total Payments
$4,073
2024 Payments
$1,506
Companies
28
Transactions
220
Medicare Patients
986
Medicare Billing
$94,343
Payment Breakdown by Category
Food & Beverage$4,073 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,073 | 220 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $768.50 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $687.96 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $390.81 | 12 | $0 (2024) |
| Amgen Inc. | $389.15 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $369.37 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $233.70 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $211.83 | 11 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $185.43 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $144.55 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $76.11 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,506 | 64 | Novo Nordisk Inc ($372.61) |
| 2023 | $1,093 | 53 | AstraZeneca Pharmaceuticals LP ($274.29) |
| 2022 | $1,051 | 62 | Boehringer Ingelheim Pharmaceuticals, Inc. ($149.20) |
| 2021 | $422.01 | 41 | Amarin Pharma Inc. ($163.76) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $29.58 | General |
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.26 | General |
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $119.92 | General |
| 11/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Vascular | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $125.50 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 159 | 204 | $45,381 | $12,848 |
| 2022 | 5 | 224 | 297 | $60,979 | $18,710 |
| 2021 | 7 | 342 | 438 | $96,776 | $37,437 |
| 2020 | 7 | 261 | 324 | $73,800 | $25,348 |
Total Patients
986
Total Services
1,263
Medicare Billing
$94,343
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 122 | $31,120 | $9,662 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,760 | $1,499 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $3,051 | $1,046 | 34.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 31 | 34 | $5,100 | $458.04 | 9.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 14 | 14 | $350.00 | $183.68 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 113 | $25,990 | $8,829 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 54 | $15,120 | $6,178 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 24 | $5,520 | $1,465 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 22 | $3,124 | $1,077 | 34.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 70 | 73 | $10,950 | $1,027 | 9.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 11 | 11 | $275.00 | $134.31 | 48.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 80 | $36,000 | $18,492 | 51.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 59 | $13,570 | $4,703 | 34.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 13 | 19 | $7,600 | $3,615 | 47.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 70 | 71 | $10,082 | $3,058 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 55 | $7,804 | $2,898 | 37.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 24 | $6,720 | $2,843 | 42.3% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 91 | 94 | $14,100 | $1,358 | 9.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 35 | 36 | $900.00 | $469.77 | 52.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2020 | 22 | 42 | $16,800 | $6,241 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 118 | $16,750 | $4,935 | 29.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 78 | $17,820 | $4,561 | 25.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2020 | 18 | 24 | $10,800 | $4,337 | 40.2% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 12 | 14 | $6,300 | $2,631 | 41.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 19 | 20 | $1,900 | $1,315 | 69.2% |
About Kathryn Neisler, MSN, APRN, FNP-C
Kathryn Neisler, MSN, APRN, FNP-C is a Family healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2018. The National Provider Identifier (NPI) number assigned to this provider is 1508347154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kathryn Neisler, MSN, APRN, FNP-C has received a total of $4,073 in payments from pharmaceutical and medical device companies, with $1,506 received in 2024. These payments were reported across 220 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,073).
As a Medicare-enrolled provider, Neisler has provided services to 986 Medicare beneficiaries, totaling 1,263 services with total Medicare billing of $94,343. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Shelbyville, IN
- Active Since 08/22/2018
- Last Updated 12/22/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1508347154
Products in Payments
- FARXIGA (Drug) $498.29
- JARDIANCE (Drug) $390.81
- Repatha (Biological) $341.51
- Vascepa (Drug) $233.70
- Ozempic (Drug) $223.05
- VERQUVO (Drug) $211.83
- LEQVIO (Drug) $199.45
- ENTRESTO (Drug) $169.92
- XARELTO (Drug) $144.55
- Inpefa (Drug) $125.50
- FASENRA (Biological) $121.18
- ELIQUIS (Drug) $110.68
- Auryxia (Drug) $69.30
- SMARTVEST (Device) $62.37
- NEXLETOL (Drug) $55.82
- Barostim Neo System (Device) $52.45
- Veltassa (Drug) $47.38
- Optimizer (Device) $38.97
- Kerendia (Drug) $38.22
- RESMETIROM (Drug) $35.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Shelbyville
Nicole Bowman, N.p, N.P
Family — Payments: $7,855
Family $7,855
Melanie Dowell, Fnp, FNP
Family — Payments: $5,128
Family $5,128
Dr. Kenda Harrison, Np, NP
Family — Payments: $4,108
Family $4,108
Mrs. Kristin Mcbay, Np-C, NP-C
Family — Payments: $3,482
Family $3,482
Arise Uwizeyimana
Family — Payments: $3,423
Family $3,423
Suzanna Carlton, Fnp, FNP
Family — Payments: $3,210
Family $3,210